Aurora Cannabis (ACB)
(Real Time Quote from BATS)
$5.28 USD
-0.12 (-2.22%)
Updated Oct 2, 2024 10:54 AM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Income Statements
Fiscal Year end for Aurora Cannabis Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 200 | NA | 175 | 191 | 208 |
Cost Of Goods | 103 | NA | 158 | 208 | 233 |
Gross Profit | 97 | NA | 17 | -17 | -25 |
Selling & Adminstrative & Depr. & Amort Expenses | 132 | 0 | 200 | 204 | 341 |
Income After Depreciation & Amortization | -34 | 0 | -183 | -221 | -366 |
Non-Operating Income | 1 | NA | -1,119 | -274 | -2,099 |
Interest Expense | 11 | NA | 57 | 52 | 58 |
Pretax Income | -44 | NA | -1,359 | -546 | -2,523 |
Income Taxes | 0 | NA | -2 | -5 | -62 |
Minority Interest | -3 | NA | 0 | 0 | 0 |
Investment Gains/Losses | 0 | NA | 0 | 0 | 0 |
Other Income/Charges | 0 | NA | 0 | 0 | 0 |
Income From Cont. Operations | -44 | NA | -1,357 | -541 | -2,461 |
Extras & Discontinued Operations | -8 | NA | 0 | -1 | -7 |
Net Income (GAAP) | -49 | NA | -1,357 | -543 | -2,468 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -7 | 0 | -109 | -144 | -280 |
Depreciation & Amortization (Cash Flow) | 27 | NA | 74 | 77 | 86 |
Income After Depreciation & Amortization | -34 | 0 | -183 | -221 | -366 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 45.61 | NA | 21.49 | 16.91 | 9.68 |
Diluted EPS Before Non-Recurring Items | -0.32 | -4.50 | -18.10 | -18.50 | -28.60 |
Diluted Net EPS (GAAP) | -1.13 | -24.90 | -63.15 | -32.10 | -255.10 |
Fiscal Year end for Aurora Cannabis Inc falls in the month of March .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 60.97 | 49.92 | 47.31 | 47.27 | 55.87 |
Cost Of Goods | 28.42 | 11.31 | 32.77 | 21.59 | 37.25 |
Gross Profit | 32.55 | 38.61 | 14.54 | 25.67 | 18.62 |
SG&A, R&D, and Dept/Amort Expenses | 31.90 | 35.29 | 32.08 | 33.91 | 30.61 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.65 | 3.32 | -17.54 | -8.24 | -11.99 |
Non-Operating Income | 6.25 | 13.08 | 0.87 | 11.67 | -0.49 |
Interest Expense | 1.27 | 1.51 | 1.89 | 3.15 | 3.97 |
Pretax Income | 5.63 | -9.45 | -18.57 | 0.29 | -16.44 |
Income Taxes | 2.09 | -0.53 | -0.05 | 0.10 | 0.07 |
Minority Interest | -1.00 | 5.08 | -1.03 | -1.20 | -5.62 |
Investment Gains/Losses | 0.00 | NA | 0.00 | 0.00 | NA |
Other Income/Charges | 0.00 | NA | 0.00 | 0.00 | NA |
Income From Cont. Operations | 3.54 | -8.93 | -18.52 | 0.19 | -16.52 |
Extras & Discontinued Operations | 0.22 | -1.03 | -0.25 | -1.78 | -4.56 |
Net Income (GAAP) | 4.76 | -15.04 | -17.74 | -0.39 | -15.45 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 51.72 | 51.52 | 47.42 | 38.40 | 35.36 |
Diluted EPS Before Non-Recurring Items | -0.11 | 0.11 | -0.20 | -0.50 | -0.40 |
Diluted Net EPS (GAAP) | 0.09 | -0.31 | -0.37 | -0.10 | -0.45 |